The MIP International Patent Forum will identify the key unique challenges faced by the
life sciences industry: how to synchronise your patent strategy for global protection in
relation to software eligibility, SEP licenses and trade secrets. Patent infringement by
equivalents will be discussed in detail to determine the impact of this decision and provide
answers to any questions that may have arisen from the judgement and application
Simon Khan Speaking at this event.